购物车
全部删除
您的购物车当前为空
FGFR-IN-22 (Compound 23) 是一种FGFR抑制剂,对FGFR1、FGFR2、FGFR3和FGFR4的IC50分别为0.631、1.26、0.851和1 nM。该化合物能够有效抑制依赖于FGFR1和FGFR3信号通路的细胞增殖,适用于慢性淋巴细胞白血病 (CLL) 等癌症的研究。

FGFR-IN-22 (Compound 23) 是一种FGFR抑制剂,对FGFR1、FGFR2、FGFR3和FGFR4的IC50分别为0.631、1.26、0.851和1 nM。该化合物能够有效抑制依赖于FGFR1和FGFR3信号通路的细胞增殖,适用于慢性淋巴细胞白血病 (CLL) 等癌症的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
FGFR-IN-22 相关产品
| 产品描述 | FGFR-IN-22 (Compound 23) is an FGFR inhibitor with IC50 values of 0.631 nM for FGFR1, 1.26 nM for FGFR2, 0.851 nM for FGFR3, and 1 nM for FGFR4. It effectively inhibits cell proliferation dependent on FGFR1 and FGFR3 signaling pathways. FGFR-IN-22 is applicable in research related to cancers such as chronic lymphocytic leukemia (CLL). |
| 靶点活性 | FGFR1:0.631 nM |
| 分子量 | 460.46 |
| 分子式 | C23H21FN8O2 |
| CAS No. | 1431872-18-2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容